Piton Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Piton Therapeutics develops first-in-class, precision therapeutics to treat inflammatory, metabolic and neurological diseases and disorders. The company has identified drug candidates to treat Ulcerative Colitis, Type 2 Diabetes and Autism Spectrum Disorder. A Parkinson's Disease pipeline is in Discovery.
The company has begun IND enabling studies for lead programs. Clinical trials are projected to start in late 2026.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}